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The H19 differentially methylated region (DMR) controls the allele-speciﬁc expression of both the imprinted H19
tumor-suppressor gene and the IGF2 growth factor. Hypermethylation of this DMR—and subsequently of the H19
promoter region—is a major cause of the clinical features of gigantism and/or asymmetry seen in Beckwith-
Wiedemann syndrome or in isolated hemihypertrophy. Here, we report a series of patients with hypomethylation
of the H19 locus. Their main clinical features of asymmetry and growth retardation are the opposite of those seen
in patients with hypermethylation of this region. In addition, we show that complete hypomethylation of the H19
promoter is found in two of three patients with the full clinical spectrum of Silver-Russell syndrome. This syndrome
is also characterized by growth retardation and asymmetry, among other clinical features. We conclude that patients
with these clinical features should be analyzed for H19 hypomethylation.
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Silver-Russell syndrome (SRS [MIM 180860]) is a clin-
ically heterogeneous syndrome, ﬁrst described by Silver
et al. (1953) and Russell (1954). Diagnosis can be dif-
ﬁcult, and at least four of the following criteria should
be present: intrauterine growth retardation (IUGR), poor
postnatal growth, relatively normal head circumference,
classic facial phenotype, and asymmetry (Price et al.
1999). At the genetic level, the syndrome is heteroge-
neous: although mostly sporadic, in familial cases, the
syndrome can be transmitted in an autosomal dominant,
autosomal recessive, and/or X-linked dominant way
(Duncan et al. 1990; Teebi 1992; Al-Fiﬁ et al. 1996;
Ounap et al. 2004). In most patients, the molecular pa-
thology of SRS is unknown; however, abnormalities have
been described for chromosome 7 (especially maternal
uniparental disomy [mUPD], in ∼10% of cases) (Monk
et al. 2002). Although, in general, complete mUPD 7 is
found in these cases, a single case was reported with a
partial mUPD 7q31-qter (Hannula et al. 2001). Analysis
of genes in this region did not lead to the identiﬁcation
of a candidate gene involved in the syndrome. Various
other chromosomal abnormalities have been described,
including trisomy 1q32.1-q42.1 (van Haelst et al. 2002),
deletion of chromosome 15q or ring chromosome 15
(Rogan et al. 1996), 18p (Christensen and Nielsen
1978), translocations involving breakpoints 17q25 (Ra-
mirez-Duenas et al. 1992) and 17q23–24 (Dorr et al.
2001), and, ﬁnally, a paternally inherited deletion of the
CSH1 gene at chromosome 17q22-24 (Eggermann et al.
1998).
In 2002, Fisher et al. (2002) reported three patients
with a phenotype that includes growth retardation. These
patients presented with maternal duplications of chromo-
some 11p15. In 2005, Eggermann et al. (2005) described
two patients with maternal duplications of 11p15 and
SRS. Recently, Gicquel and coworkers (2005) published
a series of patients with SRS who had hypomethylation
of the H19 region at 11p15 (MIM 103280).
The 11p15 region is also associated with the Beckwith-
Wiedemann syndrome (BWS [MIM 130650]), charac-
terized by macroglossia, omphalocele, fetal gigantism,
and other abnormalities, including various childhood tu-
mors (DeBaun et al. 2002). In many cases, the over-
growth is asymmetric, producing hemihypertrophy,which
is probably more accurately termed “hemihyperplasia.”
The syndrome can be caused by various molecular de-
fects, which lead to altered expression of imprinted genes
on chromosome 11p15, including H19 and IGF2 (MIM
147470) (Bliek et al. 2001) (ﬁg. 1a). Given the opposite
phenotypes of SRS and BWS, Chitayat et al. hypothe-
sized, as long ago as 1988, that the growth abnormality
and asymmetry in both disorders might be caused by
disregulation of the same gene (Chitayat et al. 1988).
Here, we report support for that hypothesis from a series
of patients with H19 hypomethylation and clinical fea-
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Figure 1 a, Schematic representation of the H19/IGF2 region of chromosome 11p15. Probe 1 is the deletion detection probe, probe 2,
the promoter methylation detection probe. CTCF-binding sites within the DMR are indicated by blackened circles. b, Results of the H19 probe
2 hybridization. MI p methylation index. c, Results of the KCNQ1OT1 hybridization. d, Results of the H19 probe 1 hybridization. P1–P9
are the patients described in this study; C1 and C2 are normal controls; H1 and H2 are patients with hemihypertrophy and hypermethylation
of H19. ND p not determined.
tures ranging from isolated asymmetry to the full clinical
spectrum of SRS.
Material and Methods
Methylation and Deletion Studies
Methylation indices of both H19 and KCNQ1OT1 (MIM
604115) were measured in blood lymphocytes as described
elsewhere (Bliek et al. 2001). In brief, DNA was digested over-
night with a methylation-sensitive restriction enzyme (NotI for
KCNQ1OT1 and SmaI for the H19 promoter), was precipi-
tated, and was digested overnight with a second restriction
enzyme (BamHI for KCNQ1OT1 and PstI for H19). Comple-
tion of digestion of the methylation-sensitive enzymewasmon-
itored by the use of control probes that recognize the non-
methylated restriction site. After Southern blotting, the ﬁlters
were hybridized with the probes listed below. Hybridization
was measured in a phosphoimager (Amersham). The Image-
quant program (Amersham) was used to measure the intensity
of the radioactive bands. The mean methylation index (inten-
sity of the measured band divided by the intensity of both
bands) (SD) for control individuals for H19 is 0.5 (0.03)
and for KCNQ1OT1 is 0.51 (0.025). Normal methylation
was deﬁned as the mean 2 SD.
Deletion studies were performed on patient DNA digested
with ApaI. After Southern blotting, the ﬁlter was hybridized
with the following probes and primer sets: deletion detection
probe (probe 1 in ﬁg. 1a), forward 5′-ATTTCCTGAGT-
CTCCCCTTGG-3′ and reverse 5′-TCGGCAAACCCTCTGT-
TCC-3′; methylation detection probe (in ﬁrst exon of H19)
(probe 2 in ﬁg. 1a), forward 5′-GTGGGAGCCAAGGAGC-
ACCTTGGACATCTG-3′ and reverse 5′-TCCTGGTGACGT-
CCTGCTGCAACTCCCCGA-3′; and methylation detection
probe (KCNQ1OT1), forward 5′-CCAGGTGAGAGGTAGT-
GGTAGAAGTC-3′ and reverse 5′-TCTTTGCATTCCTAGA-
GCAATCC-3′.
UPD Analyses
DNA containing CA repeats was ampliﬁed using standard
PCR methods. Markers were taken from the ABI PRISM Link-
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age Mapping Sets version 2.5 kit or were retrieved from the
National Center for Biotechnology Information Web site. The
PCR was done with Cy5-dCTP, and the fragments were an-
alyzed by polyacrylamide gel electrophoresis with ALFexpress
(Amersham Pharmacia). The PCR products generated with the
ABI PRISM Linkage Mapping Sets version 2.5 kit were ana-
lyzed by capillary electrophoresis by use of Genetic Analyzer
ABI310 (Applied Biosystems).
Mutation Analyses
Three primer sets were used to amplify all seven CTCF-
binding sites, described elsewhere (Bell and Felsenfeld 2000),
in the differentially methylated region (DMR) between the IGF2
and the H19 genes. The ﬁrst three sites were ampliﬁed with
the primers CTCFS1-3F, 5′-GCCCATCTTGCTGACCTCAC-
3′, and CTCFS1-3R, 5′-AGAAGACCTCCGAGAACCCTG-3′.
For CTCF site 4–6, the following primers were used: CTCFS4-
6F, 5′-GGTAGGACCCTTGTACGAGCC-3′, andCTCFS4-6R,
5′-GACCTGAAGATCTGGTGCGG-3′. For CTCF site 4, we
used the following primer set: CTCFS7F, 5′-ATTTCCTGA-
GTCTCCCCTTGG-3′, and CTCFS7R, 5′-TCGGCAAACCCT-
CTGTTCC-3′. Two additional sequence primers were used:
CTCFS site 2R, 5′-AATGTGGCTCCCATGAGTG-3′, forCTCF
site 2, and CTCF site 5R, 5′-AGAAGGGTTTCACACTAGGG-
CCG-3′, for CTCF site 5.
PCR reactions were done in a total volume of 25 ml with
MgCl2 (1.5 mM), dNTP (0.24 mM), Betaine (50 mM), primers
(1.2 mM), and 0.3 U Amplitaq Gold (Applied Biosysytems),
with an annealing temperature of 60C. After purifying the
PCR product with QIAquick PCR Puriﬁcation Kit 250 (QIA-
GEN), a sequence reaction was performed using the BigDye
Terminator v1.1. Cycle Sequencing Kit (Applied Biosystems),
with an annealing temperature of 60C. Samples were analyzed
on an ABI 310 genetic analyzer after ethanol precipitation.
Patients
Patient 1.—The patient was the third child of healthy par-
ents. She was born after a pregnancy of 40 wk and 2 d. Birth
weight was 1,870 g (3.6 SD), birth length was 41 cm (4.6
SD), and skull circumference was 33.5 cm (1 SD). In the ﬁrst
weeks, nasogastric tube feeding was necessary, and, in the ﬁrst
months, there was a failure to thrive. At age 7 mo, a ventrical
septal defect was detected. At age 8 mo, she developed cir-
culatory and respiratory insufﬁciency after gastroenteritis, fol-
lowed by multiorgan failure and postanoxic encephalopathy.
Because of severe feeding problems, she was fed by percuta-
neous gastrostomia from age 2.5 years onward. Mental de-
velopment is retarded because of encephalopathy.
Physical examination at age 2 years and 9 mo showed a
height of 87 cm (2 SD). Unfortunately, skull circumference
was not measured. She had dysmorphic features suggestive of
SRS. An iris coloboma was noted in the left eye. There was
asymmetry of the arms and legs in (left side larger) and bilateral
mild ulnar deviation of the third, fourth, and ﬁfth ﬁngers (ﬁg.
2a–2c).
Patient 2.—The patient was born after a spontaneous gemelli
pregnancy. The twin sister is healthy. Because of IUGR of the
patient, a cesarean section was performed at 35 wk and 6 d
of pregnancy. The proband had a birth weight of 1,310 g (2.4
SD) and a skull circumference of 32 cm (0.8 SD). Length at
age 2 wk was 38 cm (6.5 SD). Pathologic examination
showed dichorionic, diamniotic placentas. The placenta of the
patient was smaller than the placenta of her healthy twin sister
(1:2). DNA analysis conﬁrmed dizygosity. Postpartum, fea-
tures compatible with arthrogryposis multiplex congenitawere
present. The proband had ulnar deviation of the hands; ﬂexion
deformity of the ﬁngers, especially on her right hand; and
camptodactyly of the index ﬁnger. A luxation of the left hip,
bilateral knee luxation, and bilateral pes equinovarus defor-
mity were noted. In the ﬁrst years, she had a severe failure to
thrive. Partial nasogastric tube feeding was necessary until age
1 year and 9 mo. Mental development was normal.
Physical examination at age 4 years and 1 mo showed a
height of 84.5 cm (5 SD), a head circumference of 49.5 cm
(0.3 SD), and a weight of 9.6 kg (2.4 SD for her length).
She had facial features that suggested SRS. Two cafe´-au-lait
spots were present. Total hand length, leg length, and leg cir-
cumference were smaller on the right side than on the left side
(ﬁg. 2d–2f).
Cardiac evaluation showed two small ventricular septal de-
fects. Metabolic studies were normal except for a temporary,
isolated elevation of pipecolinic acid. An electromyography
showed no abnormalities compatible with neuropathy.
Patient 3.—The patient was born after a pregnancy of 39
wk and 3 d, with a birth weight of 1,780 g (3.6 SD), a birth
length of 40 cm (5.5 SD), and a skull circumference of 33
cm (2 SD). After birth, she underwent surgery because of am-
biguous genitalia with a large clitoris. In the ﬁrst weeks, she
was fed partially by nasogastric tube. At age 14 years, her
development is completely normal. Because of absence of
breast development and hypergonadotropic hypogonadism,
magnetic resonance imaging of the abdomen was performed
and showed absence of ovaries and a hypoplastic uterus. She
has been treated with growth hormone; her height is currently
1.60 m.
Physical examination at age 2 years showed a slender girl
with a height of 77 cm (3.3 SD), head circumference of 47.5
cm (0.3 SD), and a weight of 8,050 g (2.6 SD for her
length). She had facial characteristics of SRS. There was asym-
metry of the body (left side larger). Physical examination at
age 14 years was not allowed.
Patient 4.—Patient 4 was born after a pregnancy of 41 wk,
with a birth weight of 1,800 g (4.2 SD), a birth length of
42 cm (5 SD), and a skull circumference of 34 cm (1 SD).
He had ambiguous genitalia consisting of severe periscrotal
hypospadias and a small introitus. An atrial septal defect was
detected. Hepatosplenomegaly and a conjugated hyperbiliru-
binemia with progressive liver function disturbance was pre-
sent. Liver biopsy at age 3.5 mo showed nonspeciﬁc ﬁbrosis
and ductular proliferation. The patient had a severe failure to
thrive. Nasogastric tube feeding was necessary. He died at age
7 mo, probably as a result of an inﬂuenza pneumoniae.
Physical examination shortly after birth showed several dys-
morphic features suggestive of SRS (ﬁg. 2g). Metabolic and
endocrine investigations showed no abnormalities. Obduction
showed mild asymmetry of the arms and legs (left side larger),
severe liver cirrhosis without biliary atresia, and ﬁbrous ma-
terial in the pericardiac sac.
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Figure 2 a, Patient 1, aged 2 years and 9 mo. Note triangular, asymmetric face, long eyelashes, thin lips, and mild retrognathia. A
coloboma is present in the left eye. b, Asymmetry of the legs (left leg larger). c, Mild ulnar deviation of digits 3, 4, and 5, with shortening of
the index ﬁnger and clinodactyly of the little ﬁnger. d, Patient 2, aged 9 mo. Broad forehead; small viscerocranium; triangular, asymmetric face;
long eyelashes; thin lips with downturned corners of the mouth; and mild retrognathia. e, Asymmetry of the legs (left leg larger), internal
rotation of the left arm, ﬂexion deformity of the left wrist, and abnormal position of the feet (status after multiple surgical corrections). f,
Patient 2, aged 4 years and 1 mo. Facial features are less characteristic of SRS. g, Patient 4, aged 5 mo. Note small viscerocranium, triangular
face, large eyes with sunset phenomena, and thin lips with downturned corners of the mouth. h, Patient 9, aged 3 years and 3 mo. Note mild
asymmetry of the face (right side larger), broad forehead, ﬂat philtrum, and thin upper lip. i, Asymmetry (right side larger) of the body. j,
Asymmetry of the hands (right hand larger), mild clinodactyly of little ﬁnger.
Patient 5.—Patient 5 was born after a pregnancy of 39 wk
and 2 d, with a birth weight of 2,260 g (2.5 SD) and a birth
length of 47.5 cm (1.75 SD). Skull circumference was 32.2
cm (2.2 SD). No feeding problems were present in the neo-
natal period. Psychomotor development was normal. At age
10 years, she was referred to the orthopedic surgeon because
of leg length discrepancy and asymmetry of the arms (right
side larger). No clinical features of SRS were present.
Patient 6.—The parents of patient 6 are of Turkish descent.
The patient was born after a pregnancy of 41 wk and 3 d,
with a birth weight of 2,800 g (1.8 SD) and a birth length
of 50 cm (1 SD). Skull circumference was 35.5 cm (0.4
SD). Feeding problems started at age ∼4 mo, when she often
refused ﬂuids. At age 8 years, she was referred to the De-
partment of Medical Genetics because of growth retardation
in combination with discrepancy of leg length and circumfer-
ence (left side larger). Mental development was normal.
Physical examination at age 8 years showed a height of
119.2 cm (2 SD according to the growth curve for Turkish
children). Head circumference was 51 cm (0.5 SD). No facial
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abnormalities were present except a slightly narrow face with
thin lips. She had three small cafe´-au-lait spots.
Patient 7.—This patient was born after a pregnancy of 41
wk and 3 d, complicated with a beginning HELLP syndrome
(hemolysis, elevated liver enzyme levels, and a low platelet
count), which prompted inducing labor. She had a birth weight
of 2,560 g (2 SD). Birth length was 46 cm (3 SD). The
neonatal period was uneventful. At age 7 wk, her occipital-
frontal circumference was 38.3 cm (0 SD). Asymmetry was
noticed from birth and involved limbs and face, which clini-
cally looked more like a rightsided hemihypotrophy than he-
mihypertrophy. At age 1 year, her height was 72 cm (1.5
SD), and, at age 4 years and 9 mo, it was 109 cm (0 to 1
SD). Apart from bilateral ﬁfth ﬁnger clinodactyly, no SRS-like
features were present. The right hand showed a variant simian
crease. Otherwise, she is a healthy young girl of mixed Dutch-
Angolese descent. Her mental andmotor development has been
completely normal. Methylation studies were performed for
this patient because of body asymmetry.
Patient 8.—This patient was born after a pregnancy of 38
wk, with a birth weight of 1,500 g (3.4 SD). Information
about his birth length and skull circumference was not avail-
able. An asymmetry (left side larger) of the body was present.
Since age 23 years, he has suffered from progressive muscle
weakness in his right arm. At age 38 years, he developed in-
sulin-dependent diabetes. Recently, it was discovered that his
creatine kinase (CK) is elevated (1,264 U); the explanation of
the elevated levels is still unknown. Intelligence is normal.
Height currently is 1.70 m. He has no dysmorphic features
suggestive of SRS.
Patient 9.—This pregnancy was achieved after intracyto-
plasmic sperm injection. The patient was born after a preg-
nancy of 40 wk and 3 d, with a birth weight of 2,500 g (2
SD) and a birth length of 49 cm (1 SD). No feeding problems
were present in the neonatal period. Shortly after birth, a leg
length discrepancy of 3 cm was noted (right leg larger). Height
was 90.5 cm at age 3 years and 3 mo (2.2 SD). Physical
examination showed mild dysmorphic features (ﬁg. 2h–2j).
Her mental development has been normal.
For patients 1 and 3, a diagnosis of SRS was made. For
patients 2 and 4, the clinical features were suggestive of SRS;
however, the additional features of severe arthrogryposis mul-
tiplex congenital and liver cirrhosis have not been described
before in patients with SRS. In the remaining patients, the
diagnosis of SRS could not be made.
Chromosome analysis was performed for patients 1, 2, 3,
4, 6, 8, and 9 and showed a normal karyotype. Comparative
genome hybridization was performed for patient 2 and patient
4, and no abnormalities were detected.
Results
Methylation Studies
Methylation studies of the H19 gene on chromosome
11p15 are routinely performed in our laboratory as part
of a diagnostic test for BWS (Bliek et al. 2001). We
noticed that, in seven patients with asymmetry, the H19
promoter was hypomethylated rather than hypermethy-
lated (ﬁg. 1b, patients 2, 4, 5, 6, 7, 8, and 9). All seven
patients also exhibited IUGR or postnatal growth re-
tardation (table 1 and ﬁg. 2). This suggested to us that
the asymmetry in the patients could be due to hemi-
hypotrophy rather than hemihypertrophy. In addition,
patients 2 and 4 had an SRS-like phenotype (table 1).
Therefore, we examined patients 1 and 3 and one ad-
ditional patient, whose diagnoses were clearly SRS, ac-
cording to the criteria of Price et al. (1999). Among these
patients, patients 1 and 3 had a complete hypomethy-
lation of the H19 gene (ﬁg. 1). The third patient with
SRS had no methylation defect.
UPD Analyses
Hypermethylation ofH19 is often seen in patients with
BWS in conjunction with hypomethylation of the im-
printed KCNQ1OT1 gene, as a result of a UPD, mostly
in a mosaic form (Bliek et al. 2001). All H19 hypometh-
ylated patients had a normal methylation pattern at the
KCNQ1OT1 locus (ﬁg. 1), so we exclude mUPD of a
large part of chromosome 11p15 as an explanation for
the methylation defects seen in these patients. To further
exclude a small mUPD around the H19 gene, we ana-
lyzed a series of polymorphic markers in this region (ﬁg.
3 and table 2). In all patients, biallelic signals with nor-
mal intensity were found, excluding uniparental isodi-
somy in all cases. For patients 1, 2, 3, 6, and 7, parents
were available and uniparental heterodisomy could be
excluded. Additionally, we found no evidence of UPD-
7 in any of our patients (table 2). We conclude that UPD
around H19 is not the mechanism that leads to the H19
hypomethylation in our patient group.
Deletion Studies
Sparago et al. (2004) and Prawitt et al. (2005) dem-
onstrated that maternal inheritance of small deletions
(2–3 kb) at theH19DMR could cause hypermethylation
of H19 in patients with BWS. In our patient group, we
could exclude the existence of such deletions (ﬁg. 1);
therefore, it is unlikely that paternal inheritance of an
H19 DMR deletion would prevent methylation of this
locus during spermatogenesis and so cause the hypo-
methylation defects observed in our patients.
Sequence Analyses of the CTCF-Binding Sites
Imprinted expression of the H19/IGF2 locus depends
on a DMR that acts both as a maternal-speciﬁc, meth-
ylation-sensitive insulator and as a paternal-speciﬁc site
of hypermethylation (Bell and Felsenfeld 2000). In hu-
mans, seven repeats in DMR bind the CTCF-binding
factor on the hypomethylated maternal allele and have
been proposed as attracting methylation on the paternal
allele (Bell and Felsenfeld 2000). Binding of CTCF to
the DMR mediates the insulator function of this region
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Figure 3 a, Chromosomal order (given in megabases, from the telomere of the short arm) of chromosome 7 markers used for UPD
screening. b, Chromosomal order (given in megabases, from the telomere of the short arm) of chromosome 11 markers used for UPD screening.
and controls the reciprocal expression of the H19 and
IGF2 genes in both mouse and human. Engel and co-
workers (2004) introduced point mutations into the
mouse DMR to deplete the repeats of CpGs while re-
taining ctcf binding and enhancer blocking activity. Ma-
ternal inheritance of the mutations left h19 and Igf2
expression intact, consistent with the idea that the DMR
acts as an insulator. Conversely, paternal inheritance of
these mutations disrupted maintenance of DMR meth-
ylation, resulting in biallelic h19 expression. Further-
more, an insulator was established on the paternally in-
herited mutated allele in vivo, which reduced Igf2 ex-
pression and resulted in a 40% reduction in size of new-
born offspring. Additionally, Sparago et al. (2004) and
Gicquel et al. (2005) demonstrated aberrantmethylation
of CTCF binding sites in patients with BWS or SRS,
suggesting that mutations in the DMR repeats could
account for the loss of methylation in the H19 region
in our patients. We therefore sequenced the DMR repeat
in our patients and found all were normal (table 3).
Discussion
It is striking that two patients with SRS have complete
hypomethylation of the H19 region and that the two
patients with SRS-like features have lower methylation
indexes in blood tissue compared with the patients with
asymmetry and growth retardation without additional
SRS features. In the study by Gicquel et al. (2005), a
correlation between the degree of hypomethylation in
patients with SRS and the severity of the phenotype is
also present, but no case of complete demethylation was
reported. The complete demethylation of the patients
with SRS in our studies suggests lack of somatic mo-
saicism, at least in major parts of the fetus, and suggests
that it may have occurred prefertilization. We suggest
that the severity of the phenotype may be a result of the
tissues that are affected and how that tissue is inﬂuenced
by a change in methylation. In addition, the possibility
exists that normal cells would have a growth advantage
relative to H19 hypomethylated cells in a time- and tis-
sue-dependent manner and generate tissues with appar-
ent varying proportions ofH19 hypomethylation. Under
this hypothesis, placental hypomethylation of H19 might
be responsible for decreased placenta size and hence de-
creased body size of the fetus, as seen in the twin de-
scribed in this study. In placentas of sporadic IUGR,
downregulation of IGF2 and other paternally imprinted
genes, in conjunction with upregulation of maternally
imprinted genes, has been described by McMinn et al.
(2005). Interestingly, one of these upregulated imprinted
genes was the MEST gene (MIM 601029), localized to
the SRS region of chromosome 7.
In contrast to patients with SRS, there seems to be no
correlation between the degree of mosaicism and the
severity of the clinical features of patients with BWS and
hemihypertrophy (J.B., unpublished material).
In the present study, every patient with hypomethy-
lation of the H19 locus had prenatal and/or postnatal
growth retardation and asymmetry, an observation also
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Table 2
UPD Screening Results
CHROMOSOME AND
MARKER (LOCATION)
ALLELES BY PATIENT (METHYLATION INDEX OF H19)
P1 (.00) P2 (.18) P3 (.00) P4 (.14) P5 (.32) P6 (.36) P7 (.29) P8 (.23) P9 (.39)
7p14-q21:
D7S484 (35.1 Mb) ND NI 3/7 3/6 3/5 3/7 3/4 3/4 NI
D7S510 (38.9 Mb) ND 3/5 3/4 3/5 3/6 3/6 4/5 1/2 NI
D7S519 (45.9 Mb) ND 3/4 4/5 3/5 4/6 4/9 4/5 2/8 5/7
D7S502 (66.0 Mb) ND 3/8 2/5 NI 4/4 5/10 ND 2/3 5/7
D7S669 (77.5 Mb) ND 2/7 1/3 5/9 3/7 5/6 ND 7/10 7/8
D7S630 (88.0 Mb) ND 1/5 7/8 1/7 NI 3/7 67 4/7 6/7
7q32-36:
D7S640 (132 Mb) ND 2/7 2/4 4/6 NI 4/5 12 5/8 2/6
D7S684 (138 Mb) ND 6/7 NI NI 2/3 1/6 47 NI 1/7
D7S661 (143 Mb) ND 6/8 5/6 2/8 4/6 6/7 28 3/5 NI
D7S636 (150 Mb) ND 7/12 4/11 4/6 8/9 5/8 38 6/11 3/9
D7S798 (152 Mb) 5/6 NI 5/6 4/6 3/6 4/6 NI 5/6 3/6
11p15:
D11S2071 (0.24 Mb) 1/3 NI 3/8 2/4 ND 1/5 37 NI ND
D11S922 (1.5 Mb) NI 5/6 7/12 1/4 ND 4/7 59 6/9 ND
D11S4046 (1.9 Mb) ND NI 7/9 3/8 6/8 3/8 25 1/10 7/8
TH (2.1 Mb) ND NI NI 1/5 ND 2/3 12 ND ND
D11S1318 (2.3 Mb) 6/8 2/8 1/7 ND ND 3/7 NI ND ND
D11S988 (4.4 Mb) 6/9 4/10 7/9 6/9 ND 1/9 26 6/7 ND
D11S1338 (5.9 Mb) 1/4 NI 3/4 1/4 ND NI NI 2/4 ND
D11S902 (17 Mb) ND 7/8 ND 5/6 3/7 1/3 NI 7/8 NI
D11S904 (27 Mb) ND 2/6 2/5 6/7 1/3 4/6 23 2/5 6/7
NOTE.—When parents are available, the paternal allele is underlined and the maternal allele is in boldface italics. NDp not
done; NI p not informative.
Table 3
Sequence of the CTCF-Binding Sites in Patients 1–9
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
made, with the exception of one individual who lacked
asymmetry, by Gicquel et al. (2005). Therefore, hypo-
or hypermethylation of the H19 region is not necessarily
associated with asymmetry in SRS or BWS. In patients
of both studies, feeding problems were often present.
Besides features that can be present in SRS, additional
features were seen (table 1) that have not been previously
described in the syndrome, including iris coloboma, struc-
tural heart malformations, arthrogryposis multiplex con-
genita, absent ovaries, hypoplastic uterus, and hepato-
megaly (cirrhosis). The birth prevalence of iris coloboma
is ∼1 in 10,000 births (EUROCAT), and it is possible
that this is a chance occurrence.
The birth prevalences of ventrical septal defect and
atrial septal defect are 26 in 10,000 and 11 in 10,000,
respectively (EUROCAT). Two of our patients have a
ventrical septal defect, and one had an atrial septal de-
fect, and it is possible that, compared with the general
population, patients with H19 hypomethylation have a
higher risk for these heart defects.
Over 20% of patients with SRS have generalized camp-
todactyly, many with signs of distal arthrogryposis (Price
et al. 1999). Physical examination clearly showed bilat-
eral ulnar deviation of the third, fourth, and ﬁfth ﬁngers
in patient 1 and arthrogryposis in patient 2, and it is
possible that these features also belong to the anomalies
caused by H19 hypomethylation, with arthrogryposis
multiplex congenita as the most severe end of the spec-
trum. Genital anomalies are common in male patients
with SRS, often cryptorchism, sometimes hypospadias or
ambiguous genitalia (Price et al. 1999); Mayer-Rokitan-
sky-Kuster-Hauser syndrome (MIM 277000) has been
reported in a female with SRS with ectopic localization
of the ovaries and primary amenorrhea of adrenal origin
(Bellver-Pradas et al. 2001) and in another female with
a bicornuate uterus (Price et al. 1999). Elevated urinary
gonadotropins were described in the ﬁrst reported pa-
tients with SRS and also in later reports (Silver et al.
1953; Curi et al. 1967). We suggest that at least some
females with hypomethylation of the H19 locus do have
uterus anomalies and/or ovarian insufﬁciency. The cause
of hepatomegaly and cirrhosis in patient 4 remains un-
known. Cholestasis and cirrhosis are sometimes seen in
infants with total parenteral feeding; however, patient 4
was largely fed by nasogastric tube. It seems logical that
the generalized growth defects seen in the patients de-
scribed in this study are due to the methylation defect
at 11p15, but no data are available from the literature
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that hypomethylation of H19 also accounts for other
SRS or non-SRS features. Some of these features might
very well occur by chance.
Unlike the present study, Gicquel et al. (2005) selected
their patients on the basis of the SRS diagnosis. This
explains the more frequent occurrence of facial abnor-
malities in their study. In the study reported here, patients
were selected on the basis of asymmetry and growth re-
tardation, and we have show that the H19 hypomethy-
lation found in SRS can also be found in patients with
asymmetry and pre- and/or postnatal growth retardation
only. In seven of the nine patients, asymmetry was with
the left side larger; whether this is a chance occurrence
remains unknown. In previous reports (Price et al. 1999;
Gicquel et al. 2005), the sidedness of the asymmetry was
not mentioned.
SRS has been described elsewhere in MZ twins, all of
them discordant for the SRS phenotype (Samn et al.
1990; Bailey et al. 1995). A preponderance of female
MZ twins among patients with BWS has been described
(Weksberg et al. 2002), with the twins being discordant
for the imprinting defect at theKCNQ1OT1 locus.Weks-
berg et al. (2002) further suggested that it is possible
that unequal splitting of the inner cell mass during twin-
ning leads to differential maintenance of imprinting of
the H19 locus, and we suggest that a similar mechanism
might apply in SRS. However, data on the methylation
status of H19 in discordant MZ SRS twins are not yet
available.
DeBaun et al. (2003) found increased prevalence of
assisted reproductive technology (ART) (4.6%) in moth-
ers of patients with BWS compared with the control
population (0.8%). It has been suggested that different
factors—for example ART embryo culture conditions or
the treatment for infertility—could theoretically have an
effect on epigenetic alterations (Maher 2005), and there
is an increased incidence of IUGR in children conceived
by ART (Schieve et al. 2002). Recently, two cases of SRS
after ART were reported (Ka¨lle´n et al. 2005; Svensson
et al. 2005). Patient 9 in our series is the third reported
patient. Since H19 hypomethylation is seen not only in
patients with classic SRS but also in patients with growth
retardation and asymmetry, it seems wise to perform
methylation studies of the H19 locus in patients con-
ceived by ART who have growth retardation of unknown
cause.
Mulibrey nanism (muscle-liver-brain-eye [MIM
253250]) has several features that overlap with SRS—
for example, pre- and postnatal growth retardation, tri-
angular face, frontal bossing, and asymmetry. Some fea-
tures—like pericarditis, yellow dots in the fundi, ﬁbrous
dysplasia of long bones, and hepatomegaly—do not oc-
cur in SRS. About 4% of patients with Mulibrey nanism
develop Wilms tumor (Karlberg et al. 2004a). Recently,
hypergonadotropic premature ovarian failure with in-
complete breast development was described in Mulibrey
nanism (Karlberg et al. 2004b). Homozygous mutations
in the TRIM37 gene (MIM 605073) that are localized
close to an SRS translocation on chromosome 17q23-
q24 give rise to Mulibrey nanism (Avela et al. 2000).
Because patient 4 has some severe features of SRS in
combination with hepatomegaly, which can be present
in Mulibrey nanism, one can hypothesize that both dis-
orders are part of the same genetic pathway.
A remaining question is whether patients with hypo-
methylation of theH19 locus should be screened for intra-
abdominal embryonal tumors by ultrasound screening.
Although it is not to be expected that overexpression of
H19, a tumor-suppressor gene, and subsequent reduc-
tion of IGF2 expression would lead to tumor develop-
ment, hypomethylation ofH19 has been found in human
bladder cancer (Takai et al. 2001). In addition, tumors
have been described in association with SRS. Testicular
cancer, hepatocellular carcinoma, testicular seminoma,
craniopharyngoma, and Wilms tumor have been reported
in patients with SRS (Chitayat et al. 1988; Dang et al.
2004) but are rare. However, neither our patients nor
those reported by Gicquel et al. (2005) developed tumors.
In conclusion, we believe it is appropriate to perform
methylation studies of the H19 locus in all patients with
short stature and asymmetry, full SRS, or SR-like syn-
drome, especially when these are accompanied by feed-
ing problems. Ultrasound screening has a great impact
on the patients and their parents. In our opinion, it is
not justiﬁed to continue ultrasound screening for embry-
onal tumors conform the BWS protocol in SRS or SRS-
like patients with hypomethylation of the H19 locus.
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